Response to different therapeutic approaches in Wilson disease. A long-term follow up study

Annals of Hepatology

Volumn 11, Issue 6, 2012, Pages 907-914

  Rodríguez, Beatriz ^a   Burguera, Juan ^a   Berenguer, Marina ^b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Ceruloplasmine; Copper; D penicillamine; Zinc

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CERULOPLASMIN; COPPER; PENICILLAMINE; ZINC;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; DESCRIPTIVE RESEARCH; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER DYSFUNCTION; MALE; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; PRESCHOOL CHILD; REMISSION; SCHOOL CHILD; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WILSON DISEASE;

EID: 84869428320     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31417-6     Document Type: Article

References (23)

1. SAK W. Progressive lenticular degeneration: a familiar ner-vous disease associated with cirrosis of the liver. Brain 1912; 34: 295-507.
2. Saito T. An assessment of efficiency in potential screening for Wilson's disease. J Epidemiol Community Health 1981; 35: 274-80.
3. Bull PC TG, Rommens JM, Forbes JR, Cox DW. The Wilson Disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993; 5: 327-37.
4. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characte-rization of a human liver cDNA as a candidate gene for Wil-son disease. Biochem Biophys Res Commun 1993; 197: 271-7.
5. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper trans-porting ATPase with homology to the Menkes disease gene. Nat Genet 1993; 5: 344-50.
6. Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wil-son disease gene (ATP7B): population frequencies, geno-type-phenotype correlation, and functional analyses. Am J Hum Genet 1997; 61: 317-28.
7. Scheinberg IH, Sternlieb I. Wilson's Disease. Annu Rev Med 1965; 16: 119-34.
8. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Soc Exp Biol Med 2000; 223: 39-46.
9. Sternlieb I. Diagnosis of Wilson's disease in 1981. Gas-troenterol Clin Biol 1981; 5: 169-74.
10. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003; 23: 139-42.
11. Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical pre-sentation, diagnosis and long-term outcome of Wilson's di-sease: a cohort study. Gut 2007; 56: 115-20.
12. Maytum WJ, Goldstein NP, Mc GW, Owen CA Jr. Cop-per metabolism in Wilson's disease, Laennec's cirr-hosis and hemachromatosis: studies with radiocopper (Cu64). Proc Staff Meet Mayo Clin 1961; 36: 641-60.
13. Saito H, Watanabe K, Sahara M, Mochizuki R, Edo K, Ohya-ma Y. Triethylene-tetramine (trien) therapy for Wilson's disease. Tohoku J Exp Med 1991; 164: 29-35.
14. Walshe JM. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet 1969; 2: 1401-2.
15. Walshe JM. Wilson's disease; new oral therapy. Lancet 1956; 270: 25-6.
16. Hoogenraad TU, Koevoet R, de Ruyter Korver EG. Oral zinc sulphate as long-term treatment in Wilson's disease (hepatolenticular degeneration). Eur Neurol 1979; 18: 205-11.
17. Schilsky ML, Blank RR, Czaja MJ, Zern MA, Scheinberg IH, Stockert RJ, Sternlieb I. Hepatocellular copper toxi-city and its attenuation by zinc. J Clin Invest 1989; 84: 1562-8.
18. Brewer GJ, Dick RD, Johnson VD, Brunberg JA, Kluin KJ, Fink JK. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 1998; 132: 264-78.
19. Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Ma-nagement of Wilson's disease with zinc sulphate. Expe-rience in a series of 27 patients. J Neurol Sci 1987; 77: 137-46.
20. Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foers-ter D, Schaefer M, et al. Zinc monotherapy is not as effec-tive as chelating agents in treatment of Wilson disease. Gastroenterology 2011; 140: 1189-1198, e1.
21. Askari FK, Greenson J, Dick RD, Johnson VD, Brewer GJ. Treatment of Wilson's disease with zinc. XVIII. Ini-tial treatment of the hepatic decompensation presen-tation with trientine and zinc. J Lab Clin Med 2003; 142: 385-90.
22. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olaus-son M, et al. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002; 8: 962-7.
23. Roberts EA, Schilsky ML. Diagnosis and treatment of Wil-son disease: an update. Hepatology 2008; 47: 2089-111.